Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Technosphere Insulin vs SC Regular Insulin in T2DM
NCT00511719Phase 2Completed
- Sponsor
- MannKind
- Start
- Feb 2004
- Primary completion
- Apr 2004
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of Technosphere insulin in type 2 diabetes mellitus (T2DM), sponsored by MannKind. Started Feb 2004; status: completed.
02
Drugs
Technosphere insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00511719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00511719.